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Clinical manifestations of lichenoid tissue reactions
are heterogenous and include the cutaneous lupus
erythematosus and lichen planus. Lichenoid tissue
reactions are characterized by epidermal basal-cell
damage and a variable subepithelial inflammatory
infiltrate including cytotoxic TH1 cells and plasmacy-
toid dendritic cells. Here, we summarize the current
knowledge of the role of chemokines in the patho-
physiology of lichenoid tissue reactions and propose
mechanisms by which recruitment and local activation
of cytotoxic TH1 cells and plasmacytoid dendritic cells
may result in initiation and amplification of lichen
planus and cutaneous lupus erythematosus.
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INTRODUCTION
Chemokines are small, secreted, cytokine-like proteins that
mediate directional migration and critically regulate organ-
specific homing of leukocyte subsets (Butcher and Picker,
1996; Zlotnik and Yoshie, 2000). Most chemokines have four
characteristic cysteines. Depending on the motive displayed
by the first two cysteines, chemokines have been classified
into four subclasses (families): CC, CXC, C, and CX3C
chemokines (Zlotnik and Yoshie, 2000). The chemokine
XCL1/lymphotactin represents a structural exception to this
system, displaying solely one-cysteine residues. Chemokines
mediate a broad range of biological functions, such as
leukocyte recruitment, angiogenesis, wound healing, and
metastasis by binding to their specific receptors, which
belong to the superfamily of G-protein-coupled receptors
with seven transmembrane domains (Strieter et al., 1995;
Rossi and Zlotnik, 2000; Muller et al., 2001; Hiasa et al.,
2004). So far, 46 ligands binding to 19 human chemokine
receptors have been identified, designated as CC, CXC, XC,
or CX3C receptors (Zlotnik et al., 2006).
Chemokines can be subdivided into homeostatic and
inflammatory chemokines. The tissue- or organ-specific
expressions of homeostatic chemokines confer defined
functionality such as cell migration. In contrast, the cell-
type-specific expression of inflammatory chemokines is
dependent on adequate stimulation (Zlotnik and Yoshie,
2000). Interestingly, homeostatic chemokines and inflamma-
tory chemokines have been shown to cooperate synergisti-
cally in the recruitment of memory T cells (Vanbervliet et al.,
2003; Meller et al., 2005). In recent years, compelling
evidence has grown supporting the involvement of chemo-
kines in the pathogenesis of lichenoid tissue reactions (LTRs;
Spandau et al., 1998; Meller et al., 2007; Figure 1). LTR
comprises many clinically heterogenous skin diseases and are
defined histologically by epidermal basal-cell damage and a
band-like lymphocytic infiltration in the upper dermis. The
pathogenesis of LTRs is currently viewed as an attack and
destruction of the basal epidermal layer by autoreactive
cytotoxic T cells secreting a TH1-type cytokine profile (Iijima
et al., 2003; Shiohara and Mizukawa, 2005; Wenzel et al.,
2005). Recent evidence suggests that plasmacytoid dendritic
cells (pDCs) also infiltrate the subepidermal compartment of
LTRs and are activated to produce type I IFNs, an early key
innate event that unleashes the cytotoxic T-cell response and
the formation of LTR (Fitzgerald-Bocarsly, 1993; Farkas et al.,
2001; Meller et al., 2005; Santoro et al., 2005; de Vries et al.,
2006). Furthermore, recent findings suggest that a distinct set of
chemokines is preferentially expressed and mediates the
recruitment of pathogenic leukocyte subsets in LTRs. In contrast
to other inflammatory skin diseases such as atopic dermatitis or
psoriasis vulgaris, LTRs are characterized by the upregulation of
inflammatory CXCR3 ligands associated with the recruitment of
both effector cytotoxic T cells and pDC (Spandau et al., 1998;
Homey et al., 2000; Iijima et al., 2003; Gombert et al., 2005;
Meller et al., 2005; Wenzel et al., 2006b, 2007; Piper et al.,
2007). Cytotoxic CXCR3-positive T cells may sustain a cytolytic
immune response in LTR (De Panfilis, 1998; Sugerman et al.,
2000; Wenzel et al., 2005). Notably, atopic dermatitis or
psoriasis vulgaris did not show comparable expression levels of
CXCR3 ligands and are dominated by the expression of CCL1
and CCL20, respectively (Homey et al., 2000; Gombert et al.,
2005). Here, we summarize the current knowledge on the role
of chemokines in the pathogenesis of LTRs and present a model
for their involvement in the initiation and maintenance of
pathogenic inflammation in lichen planus (LP) and cutaneous
lupus erythematosus.
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CHEMOKINES AND LICHENOID TISSUE REACTIONS
Chemokines in the pathogenesis of cutaneous lupus
erythematosus
Cutaneous lupus erythematosus (LE) represents an autoim-
mune disease of unknown etiology (Crowson and Magro,
2001). Histologically, LE is characterized by apoptosis of
keratinocytes and a band-like inflammatory infiltrate in
superficial and/or deep compartments of the skin. Interest-
ingly, LE patients often show a marked photosensitivity and
cutaneous LE lesions often occur at sun-exposed sites. In
vitro, UV-irradiated keratinocytes release potent chemo-
attractants for lymphocytes such as CCL5/Rantes, CCL20/
MIP3a, CCL22/MDC, and CXCL8/IL-8 (Meller et al., 2005).
Furthermore, comprehensive analyses of chemokine expres-
sion demonstrated that UV-inducible chemokines such as
CCL5 and CXCL8 are among the most differentially regulated
chemokines in cutaneous LE suggesting a molecular signature
of recent UV-induced injury (Meller et al., 2005). Moreover,
UV-induced apoptosis or necrosis of keratinocytes may
promote the release of homeostatic chemokines (for example
CCL27/CTACK) from epidermal stores into the dermis (Meller
et al., 2005). Recently, the skin-specific chemokine CCL27
has been shown to play an important role during the
recruitment of CCR10-positive memory T cells into the skin
(Morales et al., 1999). This CC chemokine is abundantly and
homeostatically produced by basal keratinocytes in healthy
skin and CCL27 has been shown to bind with high affinity to
extracellular matrix components and to impregnate the
surface of dermal fibroblasts and endothelial cells (Homey
et al., 2002). Skin specimens from patients with dermatitis
solaris or, to a larger extent, early skin lesions of patients with
LE undergoing diagnostic UV irradiation, show profound
leakage of CCL27 from the basal epidermis into the papillary
dermis with impregnation of CCL27 onto endothelial cells of
the superficial plexus (Meller et al., 2005). On the contrary,
advanced and chronic cutaneous LE displaying marked
vacuolic degeneration of epidermal keratinocytes, are char-
acterized by reduced amounts of CCL27 (Meller et al., 2005).
Hence, increased matrix-bound gradients of CCL27 following
an UV-irradiation of the skin may represent an early event
during the initiation of cutaneous LE, supporting the
recruitment of a first wave of CCR10-positive skin-homing
leukocyte subsets into the skin.
Recent studies suggest that a TH1/TH2 imbalance with a
predominance of TH1 cytokines, including IFN-g, is of
pathogenic importance in autoimmune diseases such as
systemic lupus erythematosus (Akahoshi et al., 1999;
Toro et al., 2000; Gomez et al., 2004). It is well known
that IFN-g induces the expression of inflammatory
chemokines such as CXCL9, CXCL10, and CXCL11. CXCR3,
their matching receptor, is predominantly expressed on the
surface of IFN-g-producing TH1 cells (Farber, 1997; Cole
et al., 1998; Kim et al., 2001). In fact, lesions of cutaneous LE
show a marked expression of these TH1-associated chemo-
kines and their corresponding receptor CXCR3 compared to
healthy skin (Flier et al., 2001). In cutaneous LE, skin-
infiltrating leukocytes in perivascular, subepidermal, and
intraepidermal locations express CXCR3 in close anatomic
proximity with the cells expressing CXCL9 and CXCL10
(Meller et al., 2005). Moreover, human serum levels of
CXCR3 ligands were upregulated in systemic lupus
erythematosus and may reflect disease activity (Narumi
et al., 2000; Bauer et al., 2006). Taken together, IFN-g-
inducible chemokines may play a role in cutaneous
manifestations of LE, defining this entity as a putatively
TH1-associated disease.
Foxp3þ CD4þ CD25þ regulatory T cells (Treg) are critical
for the regulation of host tolerance and suppression of
pathological immune responses in autoimmune diseases and
have been shown to be diminished in cutaneous LE (Masteller
et al., 2006; Sakaguchi et al., 2006; Franz et al., 2007). In
contrast, lesional LP did not show any reduction in Treg in
skin or circulation (de Boer et al., 2007). The chemokine
repertoire of Treg in LTR remains largely unknown. Recently,
Heller et al. associated the modulation of the local balance of
the effector and regulatory T cells to CXCL10 (Heller et al.,
2006). Although overall T-cell accumulation in early athero-
sclerotic lesions in ApoE(/)/CXCL10(/) mice was
reduced, Treg number and activity were enhanced, suggesting
that the deficiency of CXCL10-mediated trafficking of
CXCR3-expressing effector T cells leads to a pronounced
regulatory phenotype (Heller et al., 2006). Hence, the
diminished numbers of Treg in cutaneous LE may partly be
explained by the CXCL10-mediated modulation of the T-cell
balance.
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Figure 1. Lichenoid tissue reaction (LTR). During the initiation of LTR, pDCs
are activated by circulating immune complexes, viruses or by self-DNA/LL37
complexes induced during skin injury, leading to the abundant production of
IFN-a. The IFN-a signal may represent an early event in the initiation of
lichenoid skin reaction. IFN-a induces the production of CXCR3 ligands in
structural cells of the skin and activates cytotoxic T cells secreting TH1
cytokines either directly or indirectly through activation of mDCs. Activated
cytotoxic TH1 cells and pDCs amplify perpetuate the production of CXCR3
ligands through secretion of IFNs leading to additional recruitment of pDC
and pathogenic T cells, and development of a LTR phenotype.
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Recently a central role of pDC in the pathogenesis of LE
has been found (Blanco et al., 2001; Ronnblom and Alm,
2001b). pDCs have the unique capacity to rapidly produce
huge amounts of IFN-a upon recognition of viral RNA and
DNA through Toll-like receptor 7 (TLR7) and 9, respectively
(Liu, 2005). Although pDCs are normally not able to respond
to self-nucleic acids, in LE pDC become activated to produce
type I IFNs by self-nucleic acids in complex with antibodies
to DNA or nucleoproteins (Ronnblom et al., 2003; Barrat
et al., 2005; Means et al., 2005). These immune complexes
trigger innate activation of pDC through TLR7 and 9 and lead
to a sustained production of type I IFN that induce an
unabated maturation of mDC and the activation of auto-
reactive T cells (Blanco et al., 2001). In systemic lupus
erythematosus the number of pDCs in the peripheral blood is
decreased and their presence, accumulation, and activation
in cutaneous lesions of LE have been reported (Cederblad
et al., 1998; Blomberg et al., 2001; Farkas et al., 2001;
Ronnblom and Alm, 2001a, 2002; Baechler et al., 2003;
Meller et al., 2005). Like T-cell-derived IFN-g, also pDC-
derived IFN-a is a potent mediator of the expression of
CXCR3 ligands. IFN-a induces in a rapid manner CXCL9,
CXCL10, and CXCL11 in primary keratinocytes, dermal
fibroblasts, and dermal endothelial cells (Meller et al.,
2005). Taken together, these observations suggest a central
role for pDCs and their secreted product, IFN-a, in the
pathogenesis of LE (Blanco et al., 2001; Ronnblom and Alm,
2001b).
Chemokines in the pathogenesis of lichen planus
LP represents an autoimmune disease of unknown etiology
(Boyd and Neldner, 1991). Clinically, LP is characterized by
a subacute or chronically progressive appearance of
polygonal papules (Boyd and Neldner, 1991). Histologically,
LP shows apoptosis of keratinocytes, acanthosis, hyper-
granulosis, and alymphocytoid cell-rich infiltrate in upper
dermis, leading to the destruction of the basal-cell layer
(Sontheimer and Gilliam, 1981). Fah et al. (1995)
demonstrated by immunohistochemical analysis a marked
induction of the IFN-a-inducible protein MxA in the upper
dermis of lesional LP compared to healthy skin. Very
recently, several studies have shown the presence and
accumulation of pDC in lesional LP (Santoro et al., 2005;
de Vries et al., 2006; Wenzel et al., 2006a). Taken together,
these results indicate that pDC were activated in LP and
produce large amounts of IFN-a. However, our knowledge of
the pathogenetic role of the chemokines in LP is fairly
incomplete. Notably, in line with the observation described
above, the induction of the IFN-a-inducible CXCR3 ligands
CXCL9, CXCL10, and CXCL11 has been reported (Spandau
et al., 1998; Flier et al., 2001; Wenzel et al., 2006a).
Furthermore, oral LP lesions show marked expression of the
inflammatory CXCR3 ligands as well as the presence of
homeostatic chemokine CXCL12 (Ichimura et al., 2006). In
oral LP, high levels of CCL20 and its receptor CCR6 were
observed, suggesting the recruitment of dendritic cell
precursors by interaction of CCL20/CCR6 (Ichimura et al.,
2006).
Chemokine-driven recruitment of pDC and cytotoxic T cells in
LTR: a self-sustaining amplification loop
During lichenoid skin inflammation a complex cocktail of
homeostatic and inflammatory mediators is present. Their
temporal and spatial distribution will determine the recruit-
ment of pathogenic leukocyte subsets. In vitro, both the
migration of pDCs and of skin-homing memory T cells is
regulated by the synergistic action of inflammatory chemo-
kines, such as CXCL9 and CXCL10 and by homeostatic
chemokines, such as CXCL12 (Vanbervliet et al., 2003;
Meller et al., 2005). In vivo analyses demonstrate that this
cooperation of chemokines is mediated by CXCL10-induced
priming of lymphocytes (Meller et al., 2005). Notably, in
cutaneous lesions of LE, CXCL12 is coexpressed at similar
anatomical locations with the inflammatory CXCR3 ligands
CXCL9 and CXCL10 (Meller et al., 2005). As mentioned
above, oral LP lesions show marked expression of these
chemokines (Ichimura et al., 2006). Hence, a synergistic
cooperation of homeostatic and inflammatory chemokines
may support the recruitment of pDC and skin-homing
memory T cells into sites of autoimmune skin inflammation
(Meller et al., 2005, 2007). Within the skin, pDC-derived
IFN-a, in concert with T-cell-derived IFN-g, may increase
chemokine production and amplify the recruitment of
leukocytes, finally leading to the development of a LTR
phenotype.
Innate activation of plasmacytoid dendritic cells in LTRs
In LE pDC appear to be activated by circulating immune
complexes consisting of autoantibodies and self-nucleic acids
(Ronnblom et al., 2003). These immune complexes are
deposited at the dermo-epidermal junction and activate
infiltrating pDC through endosomal TLR7 and 9 following
Fcg-mediated uptake (Farkas et al., 2001; Bave et al., 2003).
In LP the triggers of pDC activation are unknown. The
presence of human herpes virus type 7 in LP has been
recently linked to the presence of pDC in these lesions (de
Vries et al., 2006; de Vries et al., 2007). This finding suggests
that infection with human herpes virus type 7 , a single
stranded DNA virus, triggers pDC activation in LP through
TLR9. Also virus-specific T cells recruited in response to viral
antigens in lesional LP could mediate the cytolytic attack on
keratinocytes (De Panfilis, 1998; Pilli et al., 2002). The
development of LP lesions can be induced by local skin
injury, the so-called Koebner phenomenon. Mechanical or
chemical injury of the skin with disruption of the epidermal
permeability barrier induces the expression of the endogen-
ous antimicrobial peptide LL37 (also known as cathelicidin;
Dorschner et al., 2001; Aberg et al., 2008). Lande et al.
(2007) provided a unique explanation for the Koebner
phenomenon in psoriasis by showing that, through this
pathway, LL37 induced by skin injury triggers the activation
of pDC and the elicitation of autoimmune inflammation in
psoriasis. We propose that the Koebner phenomenon may
similarly trigger LP. Also, UV injury to the skin may trigger
pDC activation and the development of LE through the
induction of LL37. This is in accordance to the finding that
UV can trigger LL37 expression in keratinocytes (Kim et al.,
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2005). Thus, a common innate immune pathway may trigger
different downstream responses and development of different
disease entities according to genetic predisposition.
CONCLUSION
We speculate that clinical manifestations of LP and LE are
initiated by innate infiltration and -activation of pDC to
produce type I IFNs. Activation of skin pDC occurs through
deposition of circulating self-nucleic acid containing immune
complexes (in LE), through viruses infecting the skin (human
herpes virus type 7 in LP), or through mechanical injury to the
skin with the formation of LL37/self-DNA complexes
(Koebner phenomenon in LP and UV injury in LE). Self-
DNA coupled with antimicrobial peptide may induce innate
immune responses by activation of pDC leading to the
production of IFN-a. On the one hand, IFN-a mediates the
activation of IFN-g secreting cytotoxic T cells either directly
or through the bystander maturation of myeloid DC. On the
other hand, IFN-a induces the production of CXCR3 ligands
in structural cells of the skin, thus promoting the recruitment
of more cytotoxic TH1 cells and pDC into the lesion. The TH1
cytokines from cytotoxic T cells further strengthen the
production of CXCR3 ligands, finally leading to the develop-
ment of a LTR phenotype (Figure 1). Taken together,
chemokines mediate the initiation and amplification of the
pathogenic innate and adaptive immune cascade leading
LTR. Therefore, chemokine antagonists may provide new
therapeutic approaches in LTR.
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